ArticleScience advances2026
Biomimetic metamaterial-based interface for decoding heterogeneous mechanodermal activity.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human skin acts as a dynamic biomechanical interface that conveys critical physiological and behavioral information through spatiotemporally distributed deformations. Because of the limited capabilities of current sensing technologies, the spatiotemporal diversity of its mechanical cues has remained underused to date, preventing these mechanisms from being used to capture and decode the full spectrum of underlying physiological states. In this work, we define this heterogeneous set of mechanical signals as mechanodermal activity (MDA) and introduce the biomimetic metamaterial-based interface (BMMI), an engineered auxetic metamaterial substrate that reproduces the microrelief and mechanoreceptor architecture of natural skin. The BMMI allows selective capture of diverse MDA signals from adjacent skin regions with simultaneous signal amplification and noise suppression and permits straightforward modulation to accommodate various scenarios. Combined with bespoke algorithms, the wireless BMMI device decodes MDA accurately and robustly for multimodal communication interfaces, unleashing applications in health care monitoring and human-machine interaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.